Therapeutic Asset Ratings
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Azacitidine
Acute Erythroid Leukemia
Nanfang Hospital, Southern Medical University
P2
BB
(71)
Bortezomib
Waldenstrom Macroglobulinemia
Seoul National University Hospital
P2
BB
(71)
Carboplatin
Urinary Bladder Neoplasm
Merck Sharp & Dohme LLC
P2
BB
(71)
Cediranib
B-Cell Chronic Lymphocytic Leukemia
City of Hope Medical Center
P2
BB
(71)
Cediranib
Brain Cancer
National Cancer Institute (NCI)
P2
BB
(71)
Cediranib
Follicular Lymphoma
City of Hope Medical Center
P2
BB
(71)
Cediranib
Mantle Cell Lymphoma
City of Hope Medical Center
P2
BB
(71)
Cediranib
Mycosis Fungoides
National Cancer Institute (NCI)
P2
BB
(71)
Cediranib
Waldenstrom Macroglobulinemia
National Cancer Institute (NCI)
P2
BB
(71)
CIS-DIAMMINEDICHLOROPLATINUM II
Malignant Pleural Mesothelioma
AstraZeneca
P2
BB
(71)
Cyclophosphamide
Nodal Marginal Zone B-Cell Lymphoma
SWOG Cancer Research Network
P2
BB
(71)
Cyclophosphamide
Peritoneum Cancer
Peking University
P2
BB
(71)
CYCLOSPORIN A
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer Center
P2
BB
(71)
DEXAMETHASONE
Angioimmunoblastic T-Cell Lymphoma
Ou Bai, MD/PHD
P2
BB
(71)
Epirubicin
Estrogen-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Epirubicin
Progesterone-Receptor Negative Breast Cancer
Massachusetts General Hospital
P2
BB
(71)
Fludarabine
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P2
BB
(71)
Fludarabine
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
BB
(71)
Fludarabine
Hematologic Disorder
Baptist Health South Florida
P2
BB
(71)
FLUOROURACILUM
Cancer Of Unknown Primary Site
Alliance for Clinical Trials in Oncology
P2
BB
(71)
Imatinib
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
The University of Hong Kong
P2
BB
(71)
Irinotecan
Pancreatic Acinar Cell Carcinoma
Artios Pharma Ltd
P2
BB
(71)
Irinotecan
Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
BB
(71)
MOGAMULIZUMAB
Adult T-Cell Leukemia/Lymphoma
Memorial Sloan Kettering Cancer Center
P2
BB
(71)
Obinutuzumab
Richter Transformation
Christine Ryan
P2
BB
(71)
Showing 1176 to 1200 of 42,334 assets
Previous
Page 48 of 1694
Next